- Home
- QIPT vs ANIX Comparison
QIPT vs ANIX Comparison
Compare QIPT & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QIPT
- ANIX
- Stock Information
- Founded
- QIPT 1993
- ANIX 1982
- Country
- QIPT United States
- ANIX United States
- Employees
- QIPT N/A
- ANIX N/A
- Industry
- QIPT
- ANIX Biotechnology: Pharmaceutical Preparations
- Sector
- QIPT
- ANIX Health Care
- Exchange
- QIPT Nasdaq
- ANIX Nasdaq
- Market Cap
- QIPT 104.7M
- ANIX 95.7M
- IPO Year
- QIPT N/A
- ANIX 1987
- Fundamental
- Price
- QIPT $2.53
- ANIX $4.47
- Analyst Decision
- QIPT Buy
- ANIX Strong Buy
- Analyst Count
- QIPT 2
- ANIX 3
- Target Price
- QIPT $3.15
- ANIX $9.00
- AVG Volume (30 Days)
- QIPT 277.8K
- ANIX 273.7K
- Earning Date
- QIPT 08-11-2025
- ANIX 09-10-2025
- Dividend Yield
- QIPT N/A
- ANIX N/A
- EPS Growth
- QIPT N/A
- ANIX N/A
- EPS
- QIPT N/A
- ANIX N/A
- Revenue
- QIPT $238,378,000.00
- ANIX N/A
- Revenue This Year
- QIPT N/A
- ANIX N/A
- Revenue Next Year
- QIPT $28.69
- ANIX N/A
- P/E Ratio
- QIPT N/A
- ANIX N/A
- Revenue Growth
- QIPT N/A
- ANIX N/A
- 52 Week Low
- QIPT $1.35
- ANIX $2.07
- 52 Week High
- QIPT $3.27
- ANIX $4.98
- Technical
- Relative Strength Index (RSI)
- QIPT 48.82
- ANIX 65.69
- Support Level
- QIPT $2.54
- ANIX $4.21
- Resistance Level
- QIPT $2.69
- ANIX $4.98
- Average True Range (ATR)
- QIPT 0.08
- ANIX 0.32
- MACD
- QIPT -0.03
- ANIX 0.09
- Stochastic Oscillator
- QIPT 39.06
- ANIX 70.12
About QIPT Quipt Home Medical Corp.
Quipt Home Medical Corp provides in-home monitoring equipment, supplies, and services to patients. The Company operates in one business segment, which is the sale and rental of medical equipment and related devices. The company's services consist of Daily and Ambulatory Aides, Power Mobility, INR Self-Testing, Respiratory Equipment Rental, Home ventilation, Oxygen Therapy, and Sleep Apnea and PAP Treatment.
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.